Suppr
超能文献

Molecular landscape of acute promyelocytic leukemia at diagnosis and relapse.

作者信息

Fasan Annette, Haferlach Claudia, Perglerovà Karolina, Kern Wolfgang, Haferlach Torsten

机构信息

MLL Munich Leukemia Laboratory, Germany

MLL Munich Leukemia Laboratory, Germany.

出版信息

Haematologica. 2017 Jun;102(6):e222-e224. doi: 10.3324/haematol.2016.162206. Epub 2017 Mar 24.

DOI:10.3324/haematol.2016.162206

PMID:28341736

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5451348/

Abstract

摘要

相似文献

Molecular landscape of acute promyelocytic leukemia at diagnosis and relapse.

Haematologica. 2017 Jun;102(6):e222-e224. doi: 10.3324/haematol.2016.162206. Epub 2017 Mar 24.

High expression of the Ets-related gene (ERG) is an independent prognostic marker for relapse-free survival in patients with acute promyelocytic leukemia.

Ann Hematol. 2013 Apr;92(4):443-9. doi: 10.1007/s00277-012-1648-2. Epub 2012 Dec 19.

Mutations of Epigenetic Modifier Genes as a Poor Prognostic Factor in Acute Promyelocytic Leukemia Under Treatment With All-Trans Retinoic Acid and Arsenic Trioxide.

EBioMedicine. 2015 Apr 12;2(6):563-71. doi: 10.1016/j.ebiom.2015.04.006. eCollection 2015 Jun.

Cytogenetically cryptic and FISH-negative PML/RARA rearrangement in acute promyelocytic leukemia detected only by PCR: an exceedingly rare phenomenon.

Cancer Genet. 2014 Jan-Feb;207(1-2):48-9. doi: 10.1016/j.cancergen.2014.01.001. Epub 2014 Jan 16.

Clinical impact of galectin-3 in newly diagnosed t (15;17)(q22;q21)/PML-RARa acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide-based regimens.

Ann Hematol. 2017 May;96(5):711-718. doi: 10.1007/s00277-017-2948-3. Epub 2017 Feb 25.

Whole-genome sequencing and acute promyelocytic leukemia.

JAMA. 2011 Aug 10;306(6):610; author reply 610-1. doi: 10.1001/jama.2011.1108.

PML/RAR alpha transcripts monitored by polymerase chain reaction in acute promyelocytic leukemia during complete remission, relapse and after bone marrow transplantation.

Leukemia. 1996 Feb;10(2):207-12.

CNS relapse in acute promyeloctyic leukemia.

J Clin Oncol. 2010 Aug 20;28(24):e409-11. doi: 10.1200/JCO.2009.27.1577. Epub 2010 Jun 7.

High WT1 expression is an early predictor for relapse in patients with acute promyelocytic leukemia in first remission with negative PML-RARa after anthracycline-based chemotherapy: a single-center cohort study.

J Hematol Oncol. 2017 Jan 23;10(1):30. doi: 10.1186/s13045-017-0404-4.

Introducing biological features at diagnosis improves the relapse risk stratification in patients with acute promyelocytic leukemia treated with ATRA and chemotherapy.

Am J Hematol. 2015 Sep;90(9):E181-2. doi: 10.1002/ajh.24033. Epub 2015 Jul 14.

引用本文的文献

Utilization of RT-PCR and Optical Genome Mapping in Acute Promyelocytic Leukemia with Cryptic Rearrangement: A Case Discussion and Systemic Literature Review.

Genes (Basel). 2024 Dec 25;16(1):7. doi: 10.3390/genes16010007.

Predictive modelling of acute Promyelocytic leukaemia resistance to retinoic acid therapy.

Brief Bioinform. 2024 Nov 22;26(1). doi: 10.1093/bib/bbaf002.

Prognostic significance of MRD and its correlation with arsenic concentration in pediatric acute promyelocytic leukemia: a retrospective study by SCCLG-APL group.

Ther Adv Hematol. 2025 Jan 7;16:20406207241311774. doi: 10.1177/20406207241311774. eCollection 2025.

6-Gingerol modulates miRNAs and PODXL gene expression via methyltransferase enzymes in NB4 cells: an in silico and in vitro study.

Sci Rep. 2024 Aug 7;14(1):18356. doi: 10.1038/s41598-024-68069-4.

Cytoreductive chemotherapy in induction therapy plays a key role in the prognosis of patients with low-risk acute promyelocytic leukaemia.

J Cell Mol Med. 2024 May;28(10):e18252. doi: 10.1111/jcmm.18252.

Case report of pediatric TTMV-related acute promyelocytic leukemia with central nervous system infiltration and rapid accumulation of RARA-LBD mutations.

Heliyon. 2024 Feb 24;10(5):e27107. doi: 10.1016/j.heliyon.2024.e27107. eCollection 2024 Mar 15.

Risk factors and remaining challenges in the treatment of acute promyelocytic leukemia.

Int J Hematol. 2024 Nov;120(5):548-555. doi: 10.1007/s12185-023-03696-7. Epub 2024 Feb 22.

The Promise of Retinoids in the Treatment of Cancer: Neither Burnt Out Nor Fading Away.

Cancers (Basel). 2023 Jul 8;15(14):3535. doi: 10.3390/cancers15143535.

Tetra-arsenic tetra-sulfide enhances NK-92MI mediated cellular immunotherapy in all-trans retinoic acid-resistant acute promyelocytic leukemia.

Invest New Drugs. 2022 Dec;40(6):1231-1243. doi: 10.1007/s10637-022-01313-8. Epub 2022 Oct 26.

Cinobufagin induces acute promyelocytic leukaemia cell apoptosis and PML-RARA degradation in a caspase-dependent manner by inhibiting the β-catenin signalling pathway.

Pharm Biol. 2022 Dec;60(1):1801-1811. doi: 10.1080/13880209.2022.2118792.

本文引用的文献

Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia.

Leukemia. 2016 Dec;30(12):2430. doi: 10.1038/leu.2016.237. Epub 2016 Oct 7.

Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia.

Leukemia. 2016 Aug;30(8):1672-81. doi: 10.1038/leu.2016.69. Epub 2016 Apr 11.

Understanding the molecular pathogenesis of acute promyelocytic leukemia.

Best Pract Res Clin Haematol. 2014 Mar;27(1):3-9. doi: 10.1016/j.beha.2014.04.006. Epub 2014 Apr 13.

Emerging new approaches for the treatment of acute promyelocytic leukemia.

Ther Adv Hematol. 2011 Oct;2(5):335-52. doi: 10.1177/2040620711410773.

Missense mutations in PML-RARA are critical for the lack of responsiveness to arsenic trioxide treatment.

Blood. 2011 Aug 11;118(6):1600-9. doi: 10.1182/blood-2011-01-329433. Epub 2011 May 25.

Acute promyelocytic leukaemia: novel insights into the mechanisms of cure.

Nat Rev Cancer. 2010 Nov;10(11):775-83. doi: 10.1038/nrc2943. Epub 2010 Oct 22.

Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group.

Leukemia. 2005 Jul;19(7):1153-60. doi: 10.1038/sj.leu.2403790.

Frequent mutations in the ligand-binding domain of PML-RARalpha after multiple relapses of acute promyelocytic leukemia: analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in vivo.

Blood. 2002 Feb 15;99(4):1356-63. doi: 10.1182/blood.v99.4.1356.

Altered ligand binding and transcriptional regulation by mutations in the PML/RARalpha ligand-binding domain arising in retinoic acid-resistant patients with acute promyelocytic leukemia.

Blood. 2000 Nov 1;96(9):3200-8.

Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups.

Blood. 2000 Aug 15;96(4):1247-53.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Molecular landscape of acute promyelocytic leukemia at diagnosis and relapse.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译